Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Jan-Dec:22:15330338231181025.
doi: 10.1177/15330338231181025.

Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

Lian Xue  1 , Qianwen Shang  1 , Aidong Lu  1 , Yingxi Zuo  1 , Mingming Ding  1 , Leping Zhang  1 , Yueping Jia  1
Affiliations
Observational Study

Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

Lian Xue et al. Technol Cancer Res Treat. 2023 Jan-Dec.

Abstract

Purpose: To explore the diagnostic value and the prognostic significance of cerebrospinal fluid (CSF) examination by flow cytometry (FC) in children with central nervous system leukemia (CNSL). Method: This is a retrospective observational study. We select 986 pediatric patients with newly diagnosed acute lymphoblastic leukemia from January 2012 to December 2018 as the research objects and analyze the sensitivity and specificity of different methods for diagnosing CNSL. The recurrence rate and survival rate of CNSL in different groups were compared. Results: Among the 986 cases, 31 cases (positive rate of 3.14%) were positive by FC, and the cytospin-based cytomorphology (CC) test was positive in 6 cases (positive rate of 0.61%). CC combined with FC might improve the diagnostic sensitivity (from 30% to 65%, 𝑥2 value was 5.143, P = .016). The 2-year event-free survival (EFS) of 31 FC + children was 59.5% ± 9.2%, and that of 955 FC - children was 74.1% ± 1.8% (P = .004). The 2-year overall survival (OS) of the 2 groups were 63.6% ± 9.7% and 80.2% ± 1.5%, respectively (P = .004). In order to exclude the influence of CNSL, we divided the patients into 3 groups: CNSL group and non-CNSL group with CSF FC + , FC - group. There was no significant difference in EFS between FC - group and non-CNSL group with FC + (2-year EFS were 74.1% ± 1.8% and 68.7% ± 9.8%, respectively, P = .142), and there was a significant difference in OS (2-year OS were 80.2% ± 1.5% and 67.5% ± 10.3%, respectively, P = .029). Conclusion: The test of FC combined with CC may improve the diagnostic sensitivity of CNSL. The EFS and OS of children with FC + are worse than those of children with FC -. However, for those patients with non-CNSL, but only FC + at the initial diagnosis, the EFS is not significantly affected by strengthening systemic chemotherapy and increasing the number of intrathecal injections.

Keywords: acute lymphoblastic leukemia; central nervous system leukemia; cerebrospinal fluid; children; flow cytometry.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
EFS analysis of FC  +  and FC− children with acute lymphocytic disease. Two-year EFS of FC + : 59.5%  ±  9.2% and 2-year EFS of FC−: 74.1%  ±  1.8%.
Figure 2.
Figure 2.
OS analysis of FC  +  and FC− children with acute lymphocytic disease. Two-year OS of FC + : 63.6% ± 9.7% and 2-year OS of FC−: 80.2% ± 1.5%.
Figure 3.
Figure 3.
EFS analysis of the non-CNSL with CSF FC  +  group and the non-CNSL with CSF FC− group. Two-year EFS of the non-CNSL with CSF FC  +  group: 68.7% ± 9.8% and 2-year EFS of the non-CNSL with CSF FC− group: 74.1% ± 1.8%.
Figure 4.
Figure 4.
OS analysis of the non-CNSL with CSF FC  +  group and the non-CNSL with CSF FC− group. Two-year OS of the non-CNSL with CSF FC  +  group: 67.5% ± 10.3% and 2-year OS of the non-CNSL with CSF FC− group: 80.2% ± 1.5%.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Schultz KR, Pullen DJ, Sather HN, et al.Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the pediatric oncology group (POG) and children’s cancer group (CCG). Blood. 2007;109(3):926‐935. doi: 10.1182/blood-2006-01-024729. - DOI - PMC - PubMed
    1. Winick N, Devidas M, Chen S, et al.Impact of initial CSF findings on outcome among patients with national cancer institute standard- and high-risk B-cell acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol. 2017;35(22):2527‐2534. doi: 10.1200/JCO.2016.71.4774. - DOI - PMC - PubMed
    1. Levinsen M, Taskinen M, Abrahamsson J, et al.Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(8):1416‐1421. doi: 10.1002/pbc.24981. - DOI - PubMed
    1. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008;9(3):257‐268. doi: 10.1016/S1470-2045(08)70070-6. - DOI - PubMed
    1. Vora A, Andreano A, Pui CH, et al.Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy. J Clin Oncol. 2016;34(9):919‐926. doi: 10.1200/JCO.2015.64.2850. - DOI - PMC - PubMed

Publication types